Public Profile

Pt Phapros Tbk

PT Phapros Tbk, a prominent player in Indonesia's pharmaceutical industry, is headquartered in Semarang, Central Java. Established in 1971, the company has evolved significantly, marking key milestones in its commitment to healthcare innovation and quality. Specialising in the production of generic medicines, over-the-counter products, and herbal supplements, PT Phapros Tbk distinguishes itself through rigorous quality control and a diverse product portfolio. The company serves various regions across Indonesia, ensuring accessibility to essential healthcare solutions. With a strong market position, PT Phapros Tbk has garnered recognition for its contributions to public health, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its growth and enhance its reputation within the industry.

DitchCarbon Score

How does Pt Phapros Tbk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

15

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Pt Phapros Tbk's score of 15 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Let us know if this data was useful to you

Pt Phapros Tbk's reported carbon emissions

In 2023, PT Phapros Tbk reported total carbon emissions of approximately 30,000 kg CO2e, with Scope 2 emissions accounting for about 33,000 kg CO2e. This marks a significant reduction from 2022, where total emissions were about 50,000 kg CO2e, with Scope 2 emissions at approximately 9,980 kg CO2e. The company has not disclosed any Scope 1 emissions data for these years. Despite the reduction in emissions, PT Phapros Tbk has not set specific reduction targets or climate pledges, indicating a lack of formal commitments to further decrease their carbon footprint. The absence of Scope 3 emissions data suggests that the company may not be fully accounting for all indirect emissions associated with its operations. Overall, while PT Phapros Tbk has made strides in reducing its carbon emissions, the lack of defined reduction initiatives or climate commitments may limit its potential for future sustainability advancements.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
0.82
-
-
-
Scope 2
-
00,000
0,000
00,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pt Phapros Tbk's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pt Phapros Tbk is in ID, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pt Phapros Tbk is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers